Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Lidar

Showing results (21-30 of 29) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 29 results.
American Journal of Medical Genetics|August 3, 2001
Common MEFV mutations among Jewish ethnic groups in Israel: high frequency of carrier and phenotype III states and absence of a perceptible biological advantage for the carrier stateA Kogan, Y Shinar, M Lidar, et al.
Clinical Radiology|November 14, 2012
Exertional muscle pain in familial Mediterranean fever patients evaluated by MRI and 31P magnetic resonance spectroscopyT Kushnir, I Eshed, Y Heled, et al.
Lupus|April 26, 2012
Familial Mediterranean FeVer gene (MEFV) mutations as a modifier of systemic lupus erythematosusY Shinar, E Kosach, P Langevitz, et al.
European Journal of Neurology|February 9, 2011
Familial Mediterranean fever (FMF) and multiple sclerosis: an association study in one of the world's largest FMF cohortsG Yahalom, S Kivity, M Lidar, et al.
Journal of Clinical Pharmacy and Therapeutics|April 26, 2017
Anterior ST-elevation myocardial infarction induced by rituximab infusion: A case report and review of the literatureK Sharif, A Watad, N L Bragazzi, et al.
Genes and Immunity|March 8, 2013
T helper 17 polarization in familial Mediterranean feverA Ovadia, A Livneh, O Feld, et al.
Pharmacological Research|November 12, 2018
Decrease in 14-3-3η protein levels is correlated with improvement in disease activity in patients with rheumatoid arthritis treated with TofacitinibO Shovman, B Gilburd, A Watad, et al.
Best Practice & Research. Clinical Rheumatology|June 9, 2019
The diagnostic value of 14-3-3η protein levels in patients with rheumatoid arthritisO Shovman, B Gilburd, A Watad, et al.
ESMO Open|January 21, 2026
Checkpoint inhibitor effectiveness after corticosteroids and second-line immunosuppressants for immune-related adverse events in non-small-cell lung cancerE J van Dijk, M M Smeenk, F Bensch, et al.
Pageof 3

Showing results (21-30 of 29) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 29 results.
American Journal of Medical Genetics|August 3, 2001
Common MEFV mutations among Jewish ethnic groups in Israel: high frequency of carrier and phenotype III states and absence of a perceptible biological advantage for the carrier stateA Kogan, Y Shinar, M Lidar, et al.
Clinical Radiology|November 14, 2012
Exertional muscle pain in familial Mediterranean fever patients evaluated by MRI and 31P magnetic resonance spectroscopyT Kushnir, I Eshed, Y Heled, et al.
Lupus|April 26, 2012
Familial Mediterranean FeVer gene (MEFV) mutations as a modifier of systemic lupus erythematosusY Shinar, E Kosach, P Langevitz, et al.
European Journal of Neurology|February 9, 2011
Familial Mediterranean fever (FMF) and multiple sclerosis: an association study in one of the world's largest FMF cohortsG Yahalom, S Kivity, M Lidar, et al.
Journal of Clinical Pharmacy and Therapeutics|April 26, 2017
Anterior ST-elevation myocardial infarction induced by rituximab infusion: A case report and review of the literatureK Sharif, A Watad, N L Bragazzi, et al.
Genes and Immunity|March 8, 2013
T helper 17 polarization in familial Mediterranean feverA Ovadia, A Livneh, O Feld, et al.
Pharmacological Research|November 12, 2018
Decrease in 14-3-3η protein levels is correlated with improvement in disease activity in patients with rheumatoid arthritis treated with TofacitinibO Shovman, B Gilburd, A Watad, et al.
Best Practice & Research. Clinical Rheumatology|June 9, 2019
The diagnostic value of 14-3-3η protein levels in patients with rheumatoid arthritisO Shovman, B Gilburd, A Watad, et al.
ESMO Open|January 21, 2026
Checkpoint inhibitor effectiveness after corticosteroids and second-line immunosuppressants for immune-related adverse events in non-small-cell lung cancerE J van Dijk, M M Smeenk, F Bensch, et al.
Pageof 3